Bridgeway Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $25.8K | Hold |
|
|||||
|
2025
Q2 | $127K | Buy |
|
|||||
|
2025
Q1 | $82.1K | Buy |
|
|||||
|
2024
Q4 | $124K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $283K | Sell |
|
|||||
|
2019
Q4 | $629K | Buy |
|
|||||
|
2019
Q3 | $596K | Buy |
|
|||||
|
2019
Q2 | $789K | Hold |
|
|||||
|
2019
Q1 | $1.03M | Buy |
|
|||||
|
2018
Q4 | $515K | Hold |
|
|||||
|
2018
Q3 | $1.23M | Buy |
|